Nevro Corp., was founded in 2006, launched its first product in 2015, the HFX™ spinal cord stimulation (SCS) platform, which includes the Senza® SCS system to treat patients with back and leg pain.
Over those nine development years, Nevro raised $153 million while losing money every year.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
